EDePDAC | Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA
01-05-2015
-31-10-2015
Show more information
Organisation
NATIMAB THERAPEUTICS SRL